Despite its reputation, BPC-157 is still classified for research use only and has not been approved by the FDA for medical treatments
It remains a research compound that some clinics and individuals have begun using despite the lack of regulatory approval
One more thing worth flagging: media coverage in India has pointed out that the push toward quick-fix injectable "whitening" is especially common in Tier-2 and Tier-3 cities, often without proper medical evaluation
In severe cases, it can cause nerve damage, leading to numbness or tingling in the hands and feet
In additions, the differences in race (which is whites in California and black Africans in our study) might contribute for this inconsistency of findings
Quality, purity, dosing, and contamination are real concerns with gray-market suppliers